Progression of gestational hypertension to pre-eclampsia: A cohort study of 20,103 pregnancies

Pregnancy Hypertension

Volumn 10, Issue , 2017, Pages 230-237

  Chen, Kuo Hu ^a,b   Seow, Kok Min ^c,d   Chen, Li Ru ^e,f  

^a TAIPEI TZU CHI HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

^f NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

Gestational hypertension; Pre eclampsia; Pregnant weight gain; Preterm placental calcification

Indexed keywords

ADULT; ARTICLE; BODY MASS; CALCIFICATION; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GESTATIONAL AGE; GESTATIONAL WEIGHT GAIN; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL HYPERTENSION; MULTIPLE PREGNANCY; PARITY; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; TEACHING HOSPITAL; TERTIARY CARE CENTER; BODY WEIGHT GAIN; DISEASE EXACERBATION; PATHOPHYSIOLOGY; PRENATAL DIAGNOSIS; SEVERITY OF ILLNESS INDEX; TAIWAN;

ADULT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TAIWAN; WEIGHT GAIN;

EID: 85031119066     PISSN: 22107789     EISSN: 22107797     Source Type: Journal    
DOI: 10.1016/j.preghy.2017.10.001     Document Type: Article

References (51)

1. Sibai, B.M., Diagnosis and management of gestational hypertension and preeclampsia. Obstet. Gynecol. 102 (2003), 181–192.
2. Cunningham, F.G., Leveno, K.J., Bloom, S.L., Hauth, J.C., Rouse, D.J., Spong, C.Y., Prenatal care, pregnancy hypertension, and obesity. Cunningham, F.G., (eds.) Williams Obstetrics, 2010, McGraw Hill, New York 176 177 706–714, 964–965.
3. Mol, B.W., Roberts, C.T., Thangaratinam, S., Magee, L.A., de Groot, C.J., Hofmeyr, G.J., Pre-eclampsia. Lancet 387 (2016), 999–1011.
4. Pauli, J.M., Repke, J.T., Preeclampsia: short-term and long-term implications. Obstet. Gynecol. Clin. North. Am. 42 (2015), 299–313.
5. World Health Organization, Make Every Mother and Child Count, World Health Report Geneva, Switzerland, 2005.
6. Visentin, S., Londero, A.P., Bellamio, B., Giunta, G., Cosma, C., Faggian, D., Plebani, M., Cosmi, E., Fetal endothelial remodeling in late-onset gestational hypertension. Am. J. Hypertens. 29 (2016), 273–279.
7. Visentin, S., Grisan, E., Zanardo, V., Bertin, M., Veronese, E., Cavallin, F., Ambrosini, G., Trevisanuto, D., Cosmi, E., Developmental programming of cardiovascular risk in intrauterine growth-restricted twin fetuses according to aortic intima thickness. J. Ultrasound Med. 32 (2013), 279–284.
8. Veerbeek, J.H., Hermes, W., Breimer, A.Y., van Rijn, B.B., Koenen, S.V., Mol, B.W., Franx, A., de Groot, C.J., Koster, M.P., Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension 65 (2015), 600–606.
9. Farag, K., Hassan, I., Ledger, W.L., Prediction of preeclampsia: can it be achieved?. Obstet. Gynecol. Surv. 59 (2004), 464–482.
10. Barton, J.R., Sibai, B.M., Prediction and prevention of recurrent preeclampsia. Obstet. Gynecol. 112 (2008), 359–372.
11. Telang, M.A., Bhutkar, S.P., Hirwani, R.R., Analysis of patents on preeclampsia detection and diagnosis: a perspective. Placenta 34 (2013), 2–8.
12. Jeyabalan, A., Epidemiology of preeclampsia: impact of obesity. Nutr. Rev. 71:Suppl. 1 (2013), S18–S25.
13. Aliyu, M.H., Luke, S., Kristensen, S., Alio, A.P., Salihu, H.M., Joint effect of obesity and teenage pregnancy on the risk of preeclampsia: a population-based study. J. Adolesc. Health 46 (2010), 77–82.
14. Frederick, I.O., Rudra, C.B., Miller, R.S., Foster, J.C., Williams, M.A., Adult weight change, weight cycling, and prepregnancy obesity in relation to risk of preeclampsia. Epidemiology 17 (2006), 428–434.
15. O'Brien, T.E., Ray, J.G., Chan, W.S., Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 14 (2003), 368–374.
16. Arakaki, T., Hasegawa, J., Nakamura, M., Hamada, S., Muramoto, M., Takita, H., Ichizuka, K., Sekizawa, A., Prediction of early- and late-onset pregnancy-induced hypertension using placental volume on three-dimensional ultrasound and uterine artery Doppler. Ultrasound Obstet. Gynecol. 45 (2015), 539–543.
17. Prefumo, F., Sebire, N.J., Thilaganathan, B., Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices. Hum. Reprod. 19 (2004), 206–209.
18. Wang, Y., Liu, H., McKenzie, G., Witting, P.K., Stasch, J.P., Hahn, M., Changsirivathanathamrong, D., Wu, B.J., Ball, H.J., Thomas, S.R., Kapoor, V., Celermajer, D.S., Mellor, A.L., Keaney, J.F. Jr., Hunt, N.H., Stocker, R., Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat. Med. 16 (2010), 279–285.
19. Wang, Y., Re: The pathophysiology of preeclampsia: current clinical concepts. J. Obstet. Gynecol. 30 (2010), 426–427.
20. Redman, C.W., Sacks, G.P., Sargent, I.L., Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 180 (1999), 499–506.
21. Andrietti, S., Silva, M., Wright, A., Wright, D., Nicolaides, K.H., Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35–37 weeks' gestation. Ultrasound Obstet. Gynecol. 48 (2016), 72–79.
22. Espinoza, J., Romero, R., Nien, J.K., Gomez, R., Kusanovic, J.P., Goncalves, L.F., Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am. J. Obstet. Gynecol. 196:326 (2007), e1–e13.
23. Leslie, K., Thilaganathan, B., Papageorghiou, A., Early prediction and prevention of pre-eclampsia. Best Pract. Res. Clin. Obstet. Gynaecol. 25 (2011), 343–354.
24. Aquilina, J., Thompson, O., Thilaganathan, B., Harrington, K., Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. Ultrasound Obstet. Gynecol. 17 (2001), 477–484.
25. Akolekar, R., Syngelaki, A., Sarquis, R., Zvanca, M., Nicolaides, K.H., Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat. Diagn. 31 (2011), 66–74.
26. Feldstein, V.A., Harris, R.D., Machin, G.A., Ultrasound evaluation of the placenta and umbilical cord. Callen, P.W., (eds.) Ultrasonography in Obstetrics and Gynecology, 2008, Saunders, Philadelphia PA, 725–727.
27. Nolan, R.L., The placenta, membranes, umbilical cord, and amniotic fluid. Sauerbrei, E.E., Nguyen, K.T., Nolan, R.L., (eds.) A Practical Guide to Ultrasound in Obstetrics and Gynecology, 1998, Lippincott-Raven, Philadelphia PA, 438–439.
28. Spirt, B.A., Gorden, L.P., Sonography of the placenta. Fleischer, A.C., Manning, F.A., Jeanty, P., Romero, R., (eds.) Sonography in Obstetrics and GynecologyPrinciples and Practice, 2001, McGraw-Hill, New York, 195–197.
29. McKenna, D., Tharmaratnam, S., Mahsud, S., Dornan, J., Ultrasonic evidence of placental calcification at 36 weeks’ gestation: maternal and fetal outcomes. Acta. Obstet. Gynecol. Scand. 84 (2005), 7–10.
30. Chen, K.H., Chen, L.R., Lee, Y.H., Exploring the relationship between preterm placental calcification and adverse maternal and fetal outcome. Ultrasound Obstet. Gynecol. 37 (2011), 328–334.
31. Chen, K.H., Chen, L.R., Lee, Y.H., The role of preterm placental calcification in high-risk pregnancy as a predictor of poor uteroplacental blood flow and adverse pregnancy outcome. Ultrasound Med. Biol. 38 (2012), 1011–1018.
32. Chen, K.H., Seow, K.M., Chen, L.R., The role of preterm placental calcification on assessing the risks of stillbirths. Placenta 36 (2015), 1039–1044.
33. Spradley, F.T., Palei, A.C., Granger, J.P., Immune mechanisms linking obesity and preeclampsia. Biomolecules 5 (2015), 3142–3176.
34. Zavalza-Gomez, A.B., Obesity and oxidative stress: a direct link to preeclampsia?. Arch. Gynecol. Obstet. 283 (2011), 415–422.
35. Wolf, M., Kettyle, E., Sandler, L., Ecker, J.L., Roberts, J., Thadhani, R., Obesity and preeclampsia: the potential role of inflammation. Obstet. Gynecol. 98:5 Pt 1 (2001), 757–762.
36. Oyelese, Y., Vintzileos, A.M., The uses and limitations of the fetal biophysical profile. Clin. Perinatol. 38 (2011), 47–64.
37. Emmrich, P., Pathology of the placenta. X. Syncytial proliferation, calcification, cysts, pigments and metabolic disorders. Zentralbl. Pathol. 138 (1992), 77–84 (Article in German).
38. Ernst, L.M., Parkash, V., Placental pathology in fetal bartter syndrome. Pediatr. Dev. Pathol. 5 (2002), 76–79.
39. Dane, B., Dane, C., Aksoy, F., Cetin, A., Yayla, M., Antenatal Bartter syndrome: analysis of two cases with placental findings. Fetal Pediatr. Pathol. 29 (2010), 121–126.
40. Pinar, H., Carpenter, M., Placenta and umbilical cord abnormalities seen with stillbirth. Clin. Obstet. Gynecol. 53 (2010), 656–672.
41. Amir, H., Weintraub, A., Aricha-Tamir, B., Apel-Sarid, L., Holcberg, G., Sheiner, E., A piece in the puzzle of intrauterine fetal death: pathological findings in placentas from term and preterm intrauterine fetal death pregnancies. J. Maternal Fetal Neonatal Med. 22 (2009), 759–764.
42. Klaritsch, P., Haeusler, M., Karpf, E., Schlembach, D., Lang, U., Spontaneous intrauterine umbilical artery thrombosis leading to severe fetal growth restriction. Placenta 29 (2008), 374–377.
43. Anderson, H.C., Calcific diseases: a concept. Arch. Pathol. Lab. Med. 107 (1983), 341–348.
44. Poggi, S.H., Bostrom, K.I., Demer, L.L., Skinner, H.C., Koos, B.J., Placental calcification: a metastatic process?. Placenta 22 (2001), 591–596.
45. Kasznica, J.M., Petcu, E.B., Placenta calcium pump: clinical-based evidence. Pediatr. Pathol. Mol. Med. 22 (2003), 223–227.
46. Kajander, E.O., Ciftcioglu, N., Nanobacteria: an alternative mechanism for pathogenic intra- and extracellula r calcification and stone formation. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 8274–8279.
47. Kajander, E.O., Nanobacteria – propagating calcifying nanoparticles. Lett. Appl. Microbiol. 42 (2006), 549–552.
48. Agababov, R.M., Abashina, T.N., Suzina, N.E., Vainshtein, M.B., Schwartsburd, P.M., Link between the early calcium deposition in placenta and nanobacterial-like infection. J. Biosci. 32 (2007), 1163–1168.
49. Pasquinelli, G., Papadopulos, F., Nigro, M., Nanobacteria and psammoma bodies: ultrastructural observations in a case of pathological placental calcification. Ultrastruct. Pathol. 34 (2010), 344–350.
50. Lynch, A.M., Eckel, R.H., Murphy, J.R., Gibbs, R.S., West, N.A., Giclas, P.C., Salmon, J.E., Holers, V.M., Prepregnancy obesity and complement system activation in early pregnancy and the subsequent development of preeclampsia. Am. J. Obstet. Gynecol. 206:428 (2012), e1–e8.
51. Stone, C.D., Diallo, O., Shyken, J., Leet, T., The combined effect of maternal smoking and obesity on the risk of preeclampsia. J. Perinat. Med. 35 (2007), 28–31.